DE2254043C2 - LH-Releasing Hormon zur nasalen Applikation - Google Patents

LH-Releasing Hormon zur nasalen Applikation

Info

Publication number
DE2254043C2
DE2254043C2 DE2254043A DE2254043A DE2254043C2 DE 2254043 C2 DE2254043 C2 DE 2254043C2 DE 2254043 A DE2254043 A DE 2254043A DE 2254043 A DE2254043 A DE 2254043A DE 2254043 C2 DE2254043 C2 DE 2254043C2
Authority
DE
Germany
Prior art keywords
aqueous
preparation
preparations
nasal
effective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2254043A
Other languages
German (de)
English (en)
Other versions
DE2254043A1 (de
Inventor
Erich 6231 Schwalbach Ebel
Rolf Dipl.-Chem. Dr. 6000 Frankfurt Geiger
Wolfgang Dipl.-Chem. Dr. 6239 Langenhain König
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Priority to DE2254043A priority Critical patent/DE2254043C2/de
Priority to NL7314884A priority patent/NL7314884A/xx
Priority to AT925073A priority patent/AT329743B/de
Priority to ZA738459A priority patent/ZA738459B/xx
Priority to DK595973A priority patent/DK137118C/da
Priority to CA184,947A priority patent/CA1014470A/en
Priority to AU62158/73A priority patent/AU486191B2/en
Priority to BE137402A priority patent/BE806911A/xx
Priority to FR7339240A priority patent/FR2205308A1/fr
Priority to GB5132473A priority patent/GB1454105A/en
Publication of DE2254043A1 publication Critical patent/DE2254043A1/de
Application granted granted Critical
Publication of DE2254043C2 publication Critical patent/DE2254043C2/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE2254043A 1972-11-04 1972-11-04 LH-Releasing Hormon zur nasalen Applikation Expired DE2254043C2 (de)

Priority Applications (10)

Application Number Priority Date Filing Date Title
DE2254043A DE2254043C2 (de) 1972-11-04 1972-11-04 LH-Releasing Hormon zur nasalen Applikation
NL7314884A NL7314884A (cs) 1972-11-04 1973-10-30
ZA738459A ZA738459B (en) 1972-11-04 1973-11-02 Lh-releasing hormone for nasal application
DK595973A DK137118C (da) 1972-11-04 1973-11-02 Fremgangsmaade til fremstilling af et lh-rh-praeparat til nasalapplikation
AT925073A AT329743B (de) 1972-11-04 1973-11-02 Verfahren zur herstellung eines praparates zur nasalen applikation
CA184,947A CA1014470A (en) 1972-11-04 1973-11-02 Lh-releasing hormone for nasal application
AU62158/73A AU486191B2 (en) 1972-11-04 1973-11-05 Lh-releasing hormone for nasal application
BE137402A BE806911A (fr) 1972-11-04 1973-11-05 Composition hormonale liberant l'hormone luteinisante pour application par voie nasal et sa preparation
FR7339240A FR2205308A1 (en) 1972-11-04 1973-11-05 Luteal hormone-releasing hormone prepns - for treatment of hypothalamus insufficiency by intranasal admin.
GB5132473A GB1454105A (en) 1972-11-04 1973-11-05 Preparation containing luteinizing hormone-releasing factor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2254043A DE2254043C2 (de) 1972-11-04 1972-11-04 LH-Releasing Hormon zur nasalen Applikation

Publications (2)

Publication Number Publication Date
DE2254043A1 DE2254043A1 (de) 1974-05-16
DE2254043C2 true DE2254043C2 (de) 1985-01-24

Family

ID=5860826

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2254043A Expired DE2254043C2 (de) 1972-11-04 1972-11-04 LH-Releasing Hormon zur nasalen Applikation

Country Status (8)

Country Link
AT (1) AT329743B (cs)
BE (1) BE806911A (cs)
CA (1) CA1014470A (cs)
DE (1) DE2254043C2 (cs)
DK (1) DK137118C (cs)
FR (1) FR2205308A1 (cs)
NL (1) NL7314884A (cs)
ZA (1) ZA738459B (cs)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995001185A1 (en) * 1993-06-29 1995-01-12 Ferring B.V. Stabilized pharmaceutical peptide compositions

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
WO2004084859A2 (en) * 2003-03-21 2004-10-07 Nastech Pharmaceutical Company Inc. Nasal calcitonin formulations containing chlorobutanol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3169095A (en) * 1962-10-30 1965-02-09 Rexall Drug Chemical Self-propelling powder-dispensing compositions
GB1230472A (cs) * 1967-07-10 1971-05-05
NL167323C (nl) * 1970-09-26 1981-12-16 Organon Nv Werkwijze ter bereiding van een psychofarmacologisch preparaat.
BE795516A (fr) * 1972-02-17 1973-08-16 Ciba Geigy Preparations de peptides huileuses et injectables et procede pour leur preparation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995001185A1 (en) * 1993-06-29 1995-01-12 Ferring B.V. Stabilized pharmaceutical peptide compositions
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions

Also Published As

Publication number Publication date
DK137118C (da) 1978-06-26
NL7314884A (cs) 1974-05-07
FR2205308A1 (en) 1974-05-31
DE2254043A1 (de) 1974-05-16
AU6215873A (en) 1975-05-08
DK137118B (da) 1978-01-23
AT329743B (de) 1976-05-25
ATA925073A (de) 1975-08-15
CA1014470A (en) 1977-07-26
BE806911A (fr) 1974-05-06
ZA738459B (en) 1974-10-30
FR2205308B1 (cs) 1977-10-28

Similar Documents

Publication Publication Date Title
DE69908326T2 (de) Pharmazeutische zusammensetzungen für die verzögerte freisetzung von peptiden und verfahren zu deren herstellung
DE69108200T2 (de) 3-[2-(Dimethylamino)ethyl]-N-methyl-1H-indol-5-methansulfonamid Sulfat (2:1).
DE69326601T2 (de) Injektionsbehälter mit zwei kammern
DE69122494T2 (de) Vorrichtung zur transdermalen Applikation von Protein- oder Peptid-Medikamenten
EP0339506B1 (de) Orales osmotisches System mit verbesserter Haftwirkung der Membran am Kern
DE3050131T1 (de) Improvements to methods for preparing galenical preparation with delayed action and programmed release and galenical preparations for drugs obtained thereby
DE69818026T2 (de) Wässrige suspension zur nasalen verabreichung von loteprednol
DE1492015A1 (de) Verbesserte Verabreichungsform pharmazeutischer Praeparate
DE3827533A1 (de) Pharmazeutische zubereitung zur behandlung des diabetes mellitus
DE60103512T2 (de) Pharmazeutische zusammensetzung enthaltend pemetrexed zusammen mit monothioglycerol, l-cystein oder thioglykolsäure
DE69110740T2 (de) Im Dickdarm zerfallende, Polypeptide enthaltende orale Formulierungen.
DE2254043C2 (de) LH-Releasing Hormon zur nasalen Applikation
DE2451161A1 (de) Stabile prostaglandin-e-gruppen enthaltende arzneimittelzubereitung sowie verfahren zu deren herstellung
DE2323187A1 (de) Verfahren zur herstellung einer stabilisierten, pulverfoermigen secretinzubereitung durch gefriertrocknung
DE1915798C3 (de) Antacidum-Präparat in Form einer wäßrigen Suspension
CH658787A5 (de) Pharmazeutische praeparate mit gleichbleibenden elutionseigenschaften.
DE69322411T2 (de) Arzneizusammensetzungen enthaltend tandospiron oder seine analoge
DE3538619A1 (de) Arzneimittel, die isomere des hydroxyprolin enthalten
DE2243776C2 (de) Komplexe von Tetracyclinen mit Tris- (hydroxymethyl)-aminomethan, deren Herstellung und diese enthaltende Arzneimittel
EP0277462A1 (de) Verfahren zur Herstellung nasaler Lösungen enthaltend synthetisches Human calcitonin.
DE2616748A1 (de) Darmloesliche kapseln
AT401469B (de) Pharmazeutische wässrige lösung zur parenteralen anwendung enthaltend einen in situ gebildeten komplex von einem alkaloid mit bis-indol-gerüst, sowie verfahren zu deren herstellung
DE60201117T2 (de) Mikrogranulate von Ursodeoxycholsäure
WO2000056325A2 (de) Ibuprofen-lösung
DE69208171T2 (de) Gallensäuren enthaltende Arzneimittel mit verzögerter Wirkstoffabgabe

Legal Events

Date Code Title Description
OD Request for examination
8125 Change of the main classification
D2 Grant after examination
8364 No opposition during term of opposition